Koichi Kondo - Japan Medical Sr Division
| JMD Stock | EUR 3.56 0.04 1.11% |
Insider
Koichi Kondo is Sr Division of Japan Medical Dynamic
| Age | 56 |
| Phone | 81 3 3341 6705 |
| Web | https://www.jmdm.co.jp |
Japan Medical Management Efficiency
The company has return on total asset (ROA) of 0.0496 % which means that it generated a profit of $0.0496 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0758 %, meaning that it generated $0.0758 on every $100 dollars invested by stockholders. Japan Medical's management efficiency ratios could be used to measure how well Japan Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Craig Murray | High Liner Foods | N/A | |
| John Kramer | High Liner Foods | N/A | |
| Chris Mulder | High Liner Foods | N/A | |
| E Corcoran | Phibro Animal Health | 72 | |
| Anthony Rasetta | High Liner Foods | N/A | |
| Yolanda Cerezo | Ebro Foods SA | N/A | |
| J MacQuarrie | High Liner Foods | N/A | |
| Robert Pace | High Liner Foods | 64 | |
| Alfonso Barr | Ebro Foods SA | N/A | |
| Johanne McNallyMyers | High Liner Foods | N/A | |
| Paul Snow | High Liner Foods | N/A | |
| Joanne Brown | High Liner Foods | N/A | |
| David Hennigar | High Liner Foods | N/A | |
| Damian Finio | Phibro Animal Health | 53 | |
| Jonathan Bendheim | Phibro Animal Health | 47 | |
| Brian Wynn | High Liner Foods | N/A | |
| Antonio Callejas | Ebro Foods SA | N/A | |
| Ramon Fuenmayor | Phibro Animal Health | N/A | |
| Alan Bell | High Liner Foods | N/A | |
| Frank Schaayk | High Liner Foods | N/A | |
| Luis Pazos | Ebro Foods SA | N/A | |
Management Performance
| Return On Equity | 0.0758 | |||
| Return On Asset | 0.0496 |
Japan Medical Dynamic Leadership Team
Elected by the shareholders, the Japan Medical's board of directors comprises two types of representatives: Japan Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Japan. The board's role is to monitor Japan Medical's management team and ensure that shareholders' interests are well served. Japan Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Japan Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Toshiyuki Hironaka, GM Officer | ||
| Koichi Kondo, Sr Division | ||
| Yasuaki Hidaka, Sr Sale | ||
| Masao Okawa, Pres Director | ||
| Katsuhiko Seshita, Sr Division |
Japan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Japan Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0758 | |||
| Return On Asset | 0.0496 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 168.86 M | |||
| Shares Outstanding | 26.38 M | |||
| Shares Owned By Insiders | 43.07 % | |||
| Shares Owned By Institutions | 22.93 % | |||
| Price To Earning | 21.58 X | |||
| Price To Book | 1.06 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Japan Stock
Japan Medical financial ratios help investors to determine whether Japan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Japan with respect to the benefits of owning Japan Medical security.